about
Infective endocarditis: an atlas of disease progression for describing, staging, coding, and understanding the pathologyLivedo reticularis associated with the use of a midline catheterEffect of the influenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FE(NO)) and other volatiles in exhaled breathTreatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.The combined rapid detection and species-level identification of yeasts in simulated blood culture using a colorimetric sensor array.Rapid diagnostic testing for mycobacterial infections.Outcomes after surgical treatment of native and prosthetic valve infective endocarditis.Staphylococcus aureus bacteremia in solid organ transplant recipients: evidence for improved survival when compared with nontransplant patients.Endovascular infections caused by Histoplasma capsulatum: a case series and review of the literature.Rapid identification of Staphylococcus aureus and the mecA gene from BacT/ALERT blood culture bottles by using the LightCycler system.Cryptococcal iridociliary granuloma.Current Hypotheses in Cardiac Surgery: Biofilm in Infective Endocarditis.Identification of Histoplasma capsulatum from culture extracts by real-time PCR.Delayed diagnosis of Q fever endocarditis in a rheumatoid arthritis patient.Ebola Paranoia in the Age of the Internet and Social Media.Evaluation of the LightCycler Staphylococcus M GRADE kits on positive blood cultures that contained gram-positive cocci in clustersRifampin for Surgically Treated Staphylococcal Infective Endocarditis: A Propensity Score-Adjusted Cohort Study.Injection Drug Use and Outcomes After Surgical Intervention for Infective Endocarditis.Heart valve culture and sequencing to identify the infective endocarditis pathogen in surgically treated patients.Clinical utility of cerebral angiography in the preoperative assessment of endocarditis.Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones.Residual patient, anatomic, and surgical obstacles in treating active left-sided infective endocarditis.Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study.Epidemiology and risk factors for infections in myelodysplastic syndromes.Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme.Contemporary drug treatment of infective endocarditis.Rapid differentiation of methicillin-resistant and methicillin-susceptible Staphylococcus aureus by flow cytometry after brief antibiotic exposure.Decrease in Staphylococcus aureus colonization and hospital-acquired infection in a medical intensive care unit after institution of an active surveillance and decolonization program.Successful pyrosequencing of GC-rich DNA sequences by partial substitution of deoxyguanosine with deoxyinosine.Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.Antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycin.Predictive value and cost-effectiveness analysis of a rapid polymerase chain reaction for preoperative detection of nasal carriage of Staphylococcus aureus.Primary amoebic meningoencephalitis in a patient with systemic lupus erythematosus.Contribution of infectious disease consultation toward the care of inpatients being considered for community-based parenteral anti-infective therapy.Successful treatment of disseminated human papillomavirus infection with pegylated interferon and ribavirin.Current status of inpatient HIV care at a tertiary care center in Nepal.Emergency department visits during outpatient parenteral antimicrobial therapy: a retrospective cohort study.Staphylococcus lugdunensis: a rare but destructive cause of coagulase-negative staphylococcus infective endocarditis.Low incidence of Clostridium difficile infection (CDI) in patients treated with outpatient parenteral antimicrobial therapy (OPAT).Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery.
P50
Q27011898-32729588-6570-40AC-B491-07AAD3CAB61FQ28208381-D74C4BBB-FE9E-436B-B19C-071F8AB05B82Q30404880-2B8A19F7-1A09-4356-B7A0-311027C8ED1CQ34678004-D08971CD-B943-4EFD-A911-040F184D1498Q36309214-B07B996B-F9F6-4F88-B265-3A71CFCC412CQ36903835-05BF67E5-20E8-4BA0-A6D4-5CC7C1ED5DB3Q37972211-78C10C99-BF21-48AA-9B9D-B79F770D2CA6Q37987318-21309082-FFEA-490F-8EEC-727924671D43Q38014503-C9951DAC-D84A-4EE4-91CB-B1BBD3AEA2EFQ38287606-A801770E-ADD4-4ABC-BF4A-D9F824CFEC6CQ38687049-5C71C769-6933-49FB-A3A9-9100AF5B43B6Q38939001-8E2F48AD-DA04-4851-8A41-7B428EF850D6Q39735579-ACE8255C-B1D1-4BF2-B692-8F20E0F8E0EBQ40121773-FDA414E8-225F-4736-9775-F3121B6530FAQ40146244-5A66E7D7-F0F9-438B-962A-05EB40C404CCQ40709915-DBF3D0D6-02A9-4D82-999E-2C28B063DB20Q40793266-F4342A62-F9F2-4F4D-A1F5-871B5E8D25F0Q41148264-CCE2402F-9F71-4046-BD8A-6ABD363E6627Q41638946-2160BD69-4C51-4820-AD1B-2EF3F494E1A5Q41681486-74DF6E04-AD9D-42E9-A5E9-C3D329E69C9AQ42127183-F70C18A9-64B7-4193-BD93-A931BBDCD351Q42206057-D482794F-F68C-4EDC-9618-8E61D1ADE4F0Q42233850-D56515B0-980A-452A-A71A-29C313D831F0Q42248593-43392553-3795-4CA5-91A8-98DC40DA3D09Q42253702-6472FCC8-E659-436F-8C74-C3E1DE3DC06CQ42264366-800FD8B8-BE6A-45F7-8AA6-C816674D16B7Q42773098-E40D8E43-9C5A-425E-8080-3DC4F5621F78Q42995744-22F07531-4465-41A0-94A9-092976A5AFF4Q43054454-9A6056A0-FF4F-4927-995C-6AAB7D1C2223Q43408814-40749CE4-F44D-4787-B78D-ED973368446CQ44397288-EA27ED08-3DC2-4C99-A864-6B55B690B35EQ44464873-B7AF0988-61AC-4145-9440-7E699C23AE46Q44599405-9BBDFA85-5AD6-4BDB-BA8E-8888173723E8Q45289429-4E77A734-3BBE-46C0-B8B4-32E6351244F9Q50559634-6EE19ACD-C1E7-4464-996E-2277DE05F945Q51804475-019F7D75-DE2E-448F-BFAB-37D7CB6A21FEQ52569969-EC981244-3301-404B-AF5D-3EBDB55C77B7Q53621206-B1F18A91-874A-477F-9DB9-BD94B433FB14Q53626651-4050F43C-A246-4FE9-83B4-48B07759E0AFQ54599581-45A25CD3-B0BE-48FD-9492-AB00E8C5DD14
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nabin K. Shrestha
@ast
Nabin K. Shrestha
@en
Nabin K. Shrestha
@es
Nabin K. Shrestha
@sl
type
label
Nabin K. Shrestha
@ast
Nabin K. Shrestha
@en
Nabin K. Shrestha
@es
Nabin K. Shrestha
@sl
prefLabel
Nabin K. Shrestha
@ast
Nabin K. Shrestha
@en
Nabin K. Shrestha
@es
Nabin K. Shrestha
@sl
P1053
B-3600-2015
P106
P1153
7005976310
P31
P3829
P496
0000-0001-6766-9874
P569
2000-01-01T00:00:00Z